LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Strona główna・Stock List・Pfizer

Pfizer

Closed

SectorHealthcare

25.31 -1.67

Buy Sell

Overview

Share price change

24h

Current

Min

25.24

Max

25.82

Key metrics
By Trading Economics
Income	4.3B 2.7B
Sales	-3.1B 14B
P/E Sector Avg	19.702 51.415
EPS	0.75
Dividend yield	6.7
Profit margin	18.656
Employees	75,000
EBITDA	4.5B 5.2B

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+13.28% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	6.70% 2.34%
Next Earnings	4 sie 2026
Next Dividend date	12 cze 2026
Next Ex Dividend date	24 lip 2026

Market Stats
By TradingEconomics
Market Cap	-2.5B 147B
Previous open	26.98
Previous close	25.31

News Sentiment

By Acuity

47%

53%

147 / 345 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

22.855 / 23.85 Support & Resistance

Pfizer Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 maj 2026, 11:31 UTC

Earnings

Pfizer 1Q Revenue Rises But Profit Falls Amid Boosted R&D Spending

5 maj 2026, 18:12 UTC

Earnings

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 maj 2026, 13:54 UTC

Earnings

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 maj 2026, 12:35 UTC

Earnings

Pfizer Posts Better-Than-Expected Revenue, Profit -- WSJ

5 maj 2026, 11:06 UTC

Earnings

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates -- Barrons.com

5 maj 2026, 10:47 UTC

Earnings

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

5 maj 2026, 10:47 UTC

Earnings

Pfizer Still Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

5 maj 2026, 10:46 UTC

Earnings

Pfizer 1Q Revenue of Launched, Acquired Products Rose 22% Operationally >PFE

5 maj 2026, 10:46 UTC

Earnings

Pfizer 1Q Revenue Rose 7% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE

5 maj 2026, 10:45 UTC

Earnings

Pfizer Reaffirms 2026 Guidance >PFE

5 maj 2026, 10:45 UTC

Earnings

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

5 maj 2026, 10:45 UTC

Earnings

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

5 maj 2026, 10:45 UTC

Earnings

Pfizer 1Q Rev $14.5B >PFE

5 maj 2026, 10:45 UTC

Earnings

Pfizer 1Q EPS 47c >PFE

5 maj 2026, 10:45 UTC

Earnings

Pfizer 1Q Net $2.69B >PFE

5 maj 2026, 10:45 UTC

Earnings

Pfizer 1Q Adj EPS 75c >PFE

5 maj 2026, 10:36 UTC

Hot Stocks

Stocks to Watch: Palantir, HSBC, Intel, AMD -- WSJ

23 kwi 2026, 21:48 UTC

Acquisitions, Mergers, Takeovers

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 kwi 2026, 20:07 UTC

Acquisitions, Mergers, Takeovers

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 mar 2026, 11:02 UTC

Market Talk

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 mar 2026, 12:50 UTC

Earnings

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 mar 2026, 11:18 UTC

Earnings

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 mar 2026, 09:43 UTC

Hot Stocks

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 lut 2026, 21:51 UTC

Earnings

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 lut 2026, 21:17 UTC

Earnings

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 lut 2026, 21:36 UTC

Earnings

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 lut 2026, 19:56 UTC

Earnings

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 lut 2026, 19:46 UTC

Earnings

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 lut 2026, 17:35 UTC

Earnings

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 lut 2026, 17:30 UTC

Earnings

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

Peer Comparison

Price change

Pfizer Forecast

Price Target

By TipRanks

13.28% upside

12 Months Forecast

Average 29.17 USD 13.28%

High 36 USD

Low 25 USD

Based on 22 Wall Street analysts offering 12 month price targets forPfizer - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

22 ratings

Buy

Hold

Sell

Based on 22 analysts giving stock ratings to Pfizer - Dist in the past 3 months.

Technical Score

By Trading Central

22.855 / 23.85Support & Resistance

Bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

147 / 345 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.